PIP-110

N/A

Report date: 2025/12/12 15:28:40
NME

Base Information

Drug NamePIP-110
Drug Alias NamePIP-110
ClassificationSmall molecules
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsLeukemia, Promyelocytic, Acute
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIreland
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesShorla Oncology Inc
China Registration ClassN/A

Develop Information

Active CompaniesShorla Oncology Inc
Inactive CompaniesN/A
Active IndicationsLeukemia, Promyelocytic, Acute
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A